Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin J Cullen

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
CA: a Cancer Journal for Clinicians|February 21, 2019
Minimizing the burden of cancer in the United States: Goals for a high-performing health care systemK Robin Yabroff, Ted Gansler, Richard C Wender, et al.
Oral Oncology|July 18, 2015
Correlation of p16 expression and HPV type with survival in oropharyngeal squamous cell cancerSandy Z Liu, Dan P Zandberg, Lisa M Schumaker, et al.
Cancer Letters|June 21, 2011
GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy responseBaishen Chen, Xi Rao, Michael G House, et al.
American Journal of Cancer Research|July 10, 2019
Inhibition of cisplatin-resistant head and neck squamous cell carcinoma by combination of Afatinib with PD0325901, a MEK inhibitorXiaofeng Lin, Jipei Liao, Zejia Yang, et al.
American Journal of Cancer Research|December 23, 2015
IKK phosphorylation of NF-κB at serine 536 contributes to acquired cisplatin resistance in head and neck squamous cell cancerZhipeng Li, Zejia Yang, Rena G Lapidus, et al.
Molecular Cancer Research : MCR|January 17, 2012
Role of neurofilament light polypeptide in head and neck cancer chemoresistanceBaishen Chen, Ju Chen, Michael G House, et al.
The Oncologist|March 30, 2021
Adherence to Guideline-Concordant Care and Its Effect on Survival in Black Patients with Head and Neck Cancers: A SEER-Medicare AnalysisMelissa A L Vyfhuis, Ikumi Suzuki, Soren M Bentzen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosisZejia Yang, Lisa M Schumaker, Merrill J Egorin, et al.
BMC Cancer|May 24, 2019
Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathwayZejia Yang, Jipei Liao, Brandon A Carter-Cooper, et al.
Head & Neck|December 21, 2021
Comparison of efficacy and toxicity of chemoradiation regimens for head and neck squamous cell carcinoma primary treatmentMichael G McCusker, Ranee Mehra, Sania Amr, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
CA: a Cancer Journal for Clinicians|February 21, 2019
Minimizing the burden of cancer in the United States: Goals for a high-performing health care systemK Robin Yabroff, Ted Gansler, Richard C Wender, et al.
Oral Oncology|July 18, 2015
Correlation of p16 expression and HPV type with survival in oropharyngeal squamous cell cancerSandy Z Liu, Dan P Zandberg, Lisa M Schumaker, et al.
Cancer Letters|June 21, 2011
GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy responseBaishen Chen, Xi Rao, Michael G House, et al.
American Journal of Cancer Research|July 10, 2019
Inhibition of cisplatin-resistant head and neck squamous cell carcinoma by combination of Afatinib with PD0325901, a MEK inhibitorXiaofeng Lin, Jipei Liao, Zejia Yang, et al.
American Journal of Cancer Research|December 23, 2015
IKK phosphorylation of NF-κB at serine 536 contributes to acquired cisplatin resistance in head and neck squamous cell cancerZhipeng Li, Zejia Yang, Rena G Lapidus, et al.
Molecular Cancer Research : MCR|January 17, 2012
Role of neurofilament light polypeptide in head and neck cancer chemoresistanceBaishen Chen, Ju Chen, Michael G House, et al.
The Oncologist|March 30, 2021
Adherence to Guideline-Concordant Care and Its Effect on Survival in Black Patients with Head and Neck Cancers: A SEER-Medicare AnalysisMelissa A L Vyfhuis, Ikumi Suzuki, Soren M Bentzen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosisZejia Yang, Lisa M Schumaker, Merrill J Egorin, et al.
BMC Cancer|May 24, 2019
Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathwayZejia Yang, Jipei Liao, Brandon A Carter-Cooper, et al.
Head & Neck|December 21, 2021
Comparison of efficacy and toxicity of chemoradiation regimens for head and neck squamous cell carcinoma primary treatmentMichael G McCusker, Ranee Mehra, Sania Amr, et al.
Pageof 6